| # | Drug | Count |
|---|---|---|
| 0 | DOCOSANOL | 33 |
| 1 | GLYCERIN, LIDOCAINE | 33 |
| 2 | BUPRENORPHINE | 28 |
| 3 | MINOXIDIL | 21 |
| 4 | MINOXIDIL FOAM 5% (WOMENS) | 17 |
| 5 | GABAPENTIN | 16 |
| 6 | INSULIN GLARGINE | 16 |
| 7 | METFORMIN | 15 |
| 8 | ERGOCALCIFEROL | 13 |
| 9 | ESTRADIOL | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALCOHOL PADS | 1 | 0.1667 |
| 1 | FERRIC SUBSULFATE | 1 | 0.0385 |
| 2 | OXICONAZOLE NITRATE | 1 | 0.0233 |
| 3 | CANTHARIDIN | 4 | 0.0219 |
| 4 | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL | 1 | 0.0109 |
| 5 | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0102 |
| 6 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 7 | SERTACONAZOLE NITRATE | 1 | 0.0062 |
| 8 | MECHLORETHAMINE HYDROCHLORIDE | 13 | 0.0058 |
| 9 | TROLAMINE SALICYLATE | 1 | 0.0052 |
| # | Drug class | Count |
|---|---|---|
| 0 | Non-Standardized Chemical Allergen [EPC] | 34 |
| 1 | Partial Opioid Agonist [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 3 | Arteriolar Vasodilator [EPC] | 23 |
| 4 | Insulin Analog [EPC] | 23 |
| 5 | Estrogen [EPC] | 19 |
| 6 | 5-alpha Reductase Inhibitor [EPC] | 18 |
| 7 | Corticosteroid [EPC] | 17 |
| 8 | Benzodiazepine [EPC] | 15 |
| 9 | beta-Adrenergic Blocker [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 2 | Non-Standardized Chemical Allergen [EPC] | 34 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 4 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Partial Opioid Agonist [EPC] | 28 | 0.0003 |
| 6 | Arteriolar Vasodilator [EPC] | 23 | 0.0003 |
| 7 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 8 | Antiseptic [EPC] | 1 | 0.0002 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |